Addressing the challenge of platinum-resistant ovarian cancer: the role of mirvetuximab soravtansine

被引：0
|
作者：
Shaukat, Ayesha [1 ]
Shakeel, Laiba [1 ]
Khan, Afsheen [1 ]
Irfan, Hamza [2 ]
Akilimali, Aymar [3 ]
机构：
[1] Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan
[2] Shaikh Khalifa Bin Zayed Al Nahyan Med & Dent Coll, Dept Internal Med, Lahore, Pakistan
[3] Med Res Circle, Dept Res, Goma, DEM REP CONGO
来源：
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词：
EXPRESSION; CISPLATIN; WOMEN;
D O I：
10.1097/MS9.0000000000002759
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 7
页数：7
相关论文
共 50 条
  • [21] Clinicopathological Nomogram for Predicting Platinum-Resistant/Refractory Epithelial Ovarian Cancer
    Saeaib, Nungrutai
    Chaowanadisai, Siriwan
    Liabsuetrakul, Tippawan
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (02)
  • [22] Evolving treatment paradigms for platinum-resistant ovarian cancer: An update narrative review
    Lin, Hao
    Wu, Chen-Hsuan
    Fu, Hung-Chun
    Ou, Yu-Che
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (04): : 471 - 478
  • [23] Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma
    Rose, PG
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 : 18 - 22
  • [24] Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
    Zhao, Ling-Qin
    Gao, Wen
    Zhang, Ping
    Zhang, Ying-Li
    Fang, Chen-Yan
    Shou, Hua-Feng
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3739 - 3753
  • [25] Treatment of platinum-resistant recurrent ovarian cancer using a "predictive molecule targeted routine chemotherapy" system
    Zhao Xiao-dong
    Wei Feng-hua
    Zhang Yi
    He Shu-rong
    Yang Li
    CHINESE MEDICAL JOURNAL, 2009, 122 (23) : 2856 - 2860
  • [26] Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
    Zhang, Xue
    Wei, Xuan
    Bai, Gaigai
    Huang, Xueyao
    Hu, Shunxue
    Mao, Hongluan
    Liu, Peishu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8629 - 8646
  • [27] Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
    Dionisio de Sousa, Isabel J.
    Marques, Durval S.
    Principe, Catarina
    Portugal, Raquel, V
    Canberk, Sule
    Prazeres, Hugo
    Lopes, Jose M.
    Gimba, Etel R. P.
    Lima, Raquel T.
    Soares, Paula
    DIAGNOSTICS, 2020, 10 (08)
  • [28] Combination of gene set signatures correlates with response to nivolumab in platinum-resistant ovarian cancer
    Murakami, Ryusuke
    Hamanishi, Junzo
    Brown, J. B.
    Abiko, Kaoru
    Yamanoi, Koji
    Taki, Mana
    Hosoe, Yuko
    Yamaguchi, Ken
    Baba, Tsukasa
    Matsumura, Noriomi
    Konishi, Ikuo
    Mandai, Masaki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer
    Wang, Wenwen
    Cai, Jing
    Wen, Jiayi
    Li, Xinyi
    Yu, Yingjie
    Zhang, Lingpu
    Han, Qing
    Wei, Zheng
    Ma, Yujia
    Ying, Feiquan
    Xu, Xiaohan
    Li, Wenhan
    Yang, Qiang
    Sun, Si
    He, Xiaoqi
    Cai, Liqiong
    Xiao, Haihua
    Wang, Zehua
    NANO TODAY, 2022, 44
  • [30] Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
    Ganapathi, Ram N.
    Norris, Eric J.
    Sutker, Ashley P.
    Klotz, Kaitlin E.
    Ganapathi, Mahrukh K.
    FRONTIERS IN ONCOLOGY, 2020, 10
12345